Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 836 | 810 | 716 | 623 | 611 |
| Cost of Goods | 346 | 353 | 346 | 289 | 369 |
| Gross Profit | 490 | 457 | 370 | 334 | 242 |
| Operating Expenses | 1,015 | 1,020 | 1,000 | 883 | 1,065 |
| Operating Income | -179 | -211 | -285 | -260 | -454 |
| Interest Expense | 179 | 174 | 172 | 165 | 161 |
| Other Income | 61 | -27 | -22 | -12 | -15 |
| Pre-tax Income | -297 | -411 | -479 | -437 | -630 |
| Net Income Continuous | -297 | -411 | -479 | -437 | -630 |
| Net Income | $-297 | $-411 | $-479 | $-437 | $-630 |
| EPS Basic Total Ops | 0.00 | N/A | -0.14 | -0.14 | -0.14 |
| EPS Basic Continuous Ops | -0.06 | -0.08 | -0.10 | -0.09 | -0.13 |
| EPS Diluted Total Ops | 0.00 | N/A | -0.14 | -0.14 | -0.14 |
| EPS Diluted Continuous Ops | -0.06 | -0.08 | -0.10 | -0.09 | -0.13 |
| EBITDA(a) | $-126 | $-157 | $-240 | $-225 | $-416 |